Post-licensure surveillance of quadrivalent inactivated influenza (IIV4) vaccine in the United States, Vaccine Adverse Event Reporting System (VAERS), July 1, 2013−May 31, 2015

BACKGROUND: Quadrivalent inactivated influenza vaccines (IIV4) were first available for use during 2013−14 influenza season for individuals aged ≥6 months. IIV4 is designed to protect against four different flu viruses; two influenza A viruses and two influenza B viruses. METHODS: We searched the Va...

Descripción completa

Detalles Bibliográficos
Autores principales: Haber, Penina, Moro, Pedro L., Lewis, Paige, Woo, Emily Jane, Jankosky, Christopher, Cano, Maria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Science 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4916262/
https://www.ncbi.nlm.nih.gov/pubmed/27015735
http://dx.doi.org/10.1016/j.vaccine.2016.03.048

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4916262/
https://www.ncbi.nlm.nih.gov/pubmed/27015735
http://dx.doi.org/10.1016/j.vaccine.2016.03.048

Ejemplares similares